Mephebrindole, a synthetic indole analog coordinates the crosstalk between p38MAPK and eIF2 α/ATF4/CHOP signalling pathways for induction of apoptosis in human breast carcinoma cells

< h3 class= " a-plus-plus " > Abstract < /h3 > < p class= " a-plus-plus " > The efficacy of cancer chemotherapeutics is limited by side effects resulting from narrow therapeutic windows between the anticancer activity of a drug and its cytotoxicity. Thus identification of small molecules that can selectively target cancer cells has gained major interest. Cancer cells under stress utilize the Unfolded protein response (UPR) as an effective cell adaptation mechanism. The purpose of the UPR is to balance the ER folding environment and calcium homeostasis under stress. If ER stress is prolonged, tumor cells undergo apoptosis. In the present study we demonstrated an 3,3 ′-(Arylmethylene)-bis-1 < em class= " a-plus-plus " > H < /em > -indole (AMBI) derivative 3,3 ′-[(4-Methoxyphenyl) methylene]-bis-(5-bromo-1 < em class= " a-plus-plus " > H < /em > -indole), named as Mephebrindole (MPB) as an effective anti-cancer agent in breast cancer cells. MPB disrupted calcium homeostasis in MCF7 cells which triggered ER stress development. Detailed evaluations revealed that mephebrindole by activating p38MAPK also regulated GRP78 and eIF2 α/ATF4 downstream to promote apoptosis. Studies extended to in vivo allograft mice models revalidated its anti-carcinogenic property thus highlighting the role of MPB as an improved chemotherapeutic option. < /p >

Source: Apoptosis - July 7, 2016 Category: Molecular Biology Source Type: research